Introduction
Mutations in the p53 tumor suppressor protein are found in more than 50% of all human cancers (Hollstein et al., 1991 (Hollstein et al., , 1994 . Wild-type p53 contributes to the maintenance of normal cell growth and homeostasis by regulating cell cycle arrest and apoptosis (for reviews, see Agarwal et al., 1998; Levine, 1997; Prives and Hall, 1999) . As a mediator of these cellular activities, p53 has earned the title of gatekeeper for growth and division (Levine, 1997) . In response to cellular stresses such as DNA damage, heat, hypoxia and nutrient depletion, p53 is activated and induces an array of downstream target genes that execute diverse cellular pathways. Among these are p21 WAF1 , a potent inducer of cell cycle arrest (el-Deiry et al., 1993; Harper et al., 1993) , and Bax (Miyashita and Reed, 1995) and MCG10 (Zhu and Chen, 2000) , initiators of the apoptotic cascade.
A family of p53-related genes has recently emerged with the discovery of p73 and p63 (De Laurenzi et al., 1998 Kaghad et al., 1997; Osada et al., 1998; Schmale and Bamberger, 1997; Senoo et al., 1998; Trink et al., 1998; Ueda et al., 1999; Yang et al., 1998; Zaika et al., 1999) . p73 and p63 are homologous to p53 within domains critical for p53 activity, that is, the activation domain, the DNA binding domain, and the oligomerization domain (Chen, 1999; Kaelin, 1999; . p73 and p63 have been shown to transactivate a number of p53 target genes, as well as induce cell cycle arrest and apoptosis (Dohn et al., 2001; Jost et al., 1997; Osada et al., 1998; Shimada et al., 1999; Yang et al., 1998; Zhu et al., 1998a) . p73 and p63 exist in multiple isoforms, each diering in the length of their C-termini (Kaelin, 1999; Levrero et al., 2000; . Transcription from an alternative start site within intron 3 can produce N-terminal truncations (DN) of both p73 and p63 (Yang et al., 1998 . These DN variants lack the acidic N-terminus corresponding to the N-terminal activation domain of p53. DNp73 and DNp63 are therefore thought to be transcriptionally inactive and act as dominant negative isoforms (Yang et al., 1998 . However, evidence exists that additional activation domains are present within the p53 family proteins (Candau et al., 1997; Dohn et al., 2001; Ozaki et al., 1999; Zhu et al., 1998b) . Two activation domains have been found in the p53 Nterminus (Candau et al., 1997; Zhu et al., 1998b) , and a C-terminal regulatory domain within p73 can enhance the protein's ability to induce apoptosis (Ozaki et al., 1999) . Furthermore, a second activation domain within the N-terminus of DNp63a renders the protein transcriptionally active and capable of inducing cell cycle arrest and apoptosis (Dohn et al., 2001) . Consequently, the activities and functions of p53 family members and their DN variants need further examination.
A cell's ability to modulate activity in response to environmental cues often relies upon the transduction of extracellular signals via plasma membrane proteins. One such class of these proteins is the Eph family of receptor tyrosine kinases. Consisting of at least 14 distinct receptors and eight membrane-bound ligands, known as the ephrins, the Eph family is the largest family of receptor tyrosine kinases (Eph Nomenclature Committee, 1997) . Eph proteins are divided into two subfamilies: the EphA receptors (A1 ± A8) that bind glycosyl phosphatidylinositol (GPI)-linked ephrin-A ligands (A1 ± A5), and the EphB receptors (B1 ± B6) that bind transmembrane ephrin-B ligands (B1 ± B3) (Eph Nomenclature Committee, 1997) . The only known crosstalk between the A and B subfamilies occurs with the EphA4 receptor, which can bind ephrins-B2 and -B3 as well as the entire A subclass (Gale et al., 1996; O'Leary and Wilkinson, 1999) . There is a great deal of redundancy of receptor-ligand binding speci®city within each subfamily, although binding anities vary (Flanagan and Vanderhaeghen, 1998; Gale et al., 1996) .
Eph receptors and their ephrin ligands are expressed in most embryonic tissues at regions of cell ± cell contact (Gale et al., 1996) . Complementary expression of receptors and ligands is thought to allow Eph ± ephrin interactions to mediate cell sorting and prevent intermingling of distinct cell populations Xu et al., 1999) . Additional studies have implicated the graded distributions of Eph receptors and ephrin ligands in the topographical guidance of migrating neurons (Cheng et al., 1995; Frisen et al., 1998; Henkemeyer et al., 1996; O'Leary and Wilkinson, 1999) . Although Eph family members are well characterized for their roles and widespread expression in embryonic development (Flanagan and Vanderhaeghen, 1998; Frisen et al., 1999; Holder and Klein, 1999; O'Leary and Wilkinson, 1999) , in the adult, expression of the EphA2 receptor is found predominantly in epithelial tissues (Lindberg and Hunter, 1990) . Recent evidence implicates activated EphA2 as a negative regulator of cell adhesion and proliferation via the disruption of focal adhesions and the inhibition of the Ras/MAPK pathway (Miao et al., 2000 (Miao et al., , 2001 Zantek et al., 1999) Here we show that p53 regulates the EphA2 receptor tyrosine kinase. We demonstrate that EphA2 is also regulated by other members of the p53 family, that is, p73 and p63. Activation of EphA2 was induced by DNA damage in a time-dependent manner that correlated with stabilization of p53. A p53 response element located within the EphA2 promoter is responsive to wild-type p53, p73, and p63, but not mutant p53 or p73. By generating stable H1299 and MCF-7 cell lines that inducibly express EphA2 under a tetracycline-repressible promoter, we found that EphA2 inhibits cell proliferation by inducing apoptosis, as measured by DNA histogram analysis and apoptotic cell staining assays. Furthermore, we found that ephrin-A1, a cognate ligand for EphA2, is regulated by both p53 and p73. These ®ndings implicate the EphA2 receptor tyrosine kinase, and possibly other members of the Eph family of receptors and ligands, as mediators of p53-induced apoptosis.
Results

Upregulation of EphA2 by p53 family members
To identity novel target genes regulated by p53, we performed ClonTech PCR-select cDNA subtraction (Clontech Laboratories, Inc., Palo Alto, CA, USA) using mRNA isolated from p53-3 cells, a derivative of the H1299 cell line generated to inducibly express wildtype p53 under the control of a tetracycline-repressible promoter. Several cDNA fragments representing potential p53 target genes were isolated, and subsequent sequencing revealed EphA2 as a potential target of p53 induction. To con®rm the regulation of EphA2 by p53, we performed a series of Northern blots using total RNA from cell lines of various p53 status. p53-3 and p53 (R249S)-4 inducibly express wild-type and mutant p53, respectively, in p53-null H1299 cells (Chen et al., 1996; Zhu et al., 1999) . Similarly, p53-7 inducibly expresses wild-type p53 in p53-null Saos-2 cells. We found that induction of wild-type p53 in p53-3 and p53-7 cell lines resulted in an increase in EphA2 transcript levels ( Figure 1a , upper panel, compare lanes 2 with 1, 6 with 5). However, expression of mutant p53 did not increase EphA2 transcript levels ( Figure 1a , upper panel, compare lane 4 with 3). Similarly, treatment of cell lines containing endogenous wild-type p53 (HCT116, 80S14 and LS174T) with the DNA damaging agent camptothecin resulted in an increase in EphA2 transcript levels ( Figure 1b , upper panel, compare lanes 2, 4 and 8 with lanes 1, 3 and 7 respectively). However, EphA2 transcript levels were not increased in a wild-type p53 cell line expressing human papilloma virus (HPV)-derived E6 protein (HCT116-E6), which targets p53 for ubiquitinmediated degradation (Schener et al., 1993) ( -independent. Levels of p21 WAF1 transcript were assayed as a positive control for wild-type p53 activation, and GAPDH levels were assayed as a loading control (Figure 1a , b, lower panels).
Next, we determined whether an increase of EphA2 transcript levels correlates with an increase in EphA2 protein levels. Tetracycline withdrawal induced exogenous p53 in p53-inducible cell lines (Figure 1c The p53 homologs p73 and p63 have been shown to transactivate reporter constructs containing p53 response elements and dierentially activate a number of endogenous p53 target genes (Dohn et al., 2001; Jost et al., 1997; Osada et al., 1998; Shimada et al., 1999; Yang et al., 1998; Zhu et al., 1998a) . To examine whether EphA2 is regulated by other members of the p53 family, we performed Northern blot analysis with an MCF-7 cell line generated to inducibly express p73b. This unique cell line is capable of co-expressing p73b by withdrawal of tetracycline and endogenous p53 by treating the cells with camptothecin. We found that like p53, p73b was able to increase EphA2 transcript levels ( Figure 2a ). Co-expression of p73b and p53 produced an additive induction of both EphA2 transcript and protein levels (Figure 2a, b) . To determine whether p63 can also regulate EphA2, we performed Western blot analysis using cell extracts from an H1299 cell line that inducibly expresses p63a. We found that like p53 and p73, p63a was able to increase EphA2 protein expression (Figure 2c ).
DNA damage induces EphA2 phosphorylation
Phosphorylation of receptor tyrosine kinases is indicative of activation of the catalytic domains (van der Geer et al., 1994) . To determine whether EphA2 is phosphorylated in response to DNA damage, we immunoprecipitated EphA2 from cells treated with the DNA damaging agent camptothecin (Figure 3a) . In HCT116 and MCF-7 cells, both of which contain endogenous wild-type p53, EphA2 protein levels were increased upon treatment with the DNA damaging agent camptothecin (+) for 24 h (Figure 3a , lower panel). When cell lysates were immunoprecipitated with anti-phosphotyrosine antibodies, we found that the phosphorylated EphA2 was increased upon DNA damage ( Figure 3a , upper panel). Since upregulation of EphA2 is p53-dependent in HCT116 cells (see Figure  2b ), we further characterized the activation of EphA2 in HCT116 cells treated with camptothecin for 0, 2, 4, 6, 8, 12, 18 and 24 h. We found that accumulation of p53 led to increased levels of EphA2 expression ( Figure  3b ). Furthermore, EphA2 phosphorylation was in- WAF1 (lower panel), and GAPDH (lower panel) in p53-inducible cell lines were determined by Northern blot analysis using 10 mg total RNA. Total RNA was puri®ed from p53-3, p53-7, and p53(R249S)-4 cells that were uninduced (7) and induced (+) by tetracycline withdrawal for 24 h. The relative fold increase in mRNA expression is shown numerically below the upper panel. (b) Endogenous p53 upregulates EphA2 transcript. Transcript levels of EphA2 (upper panel), p21
WAF1
(lower panel), and GAPDH (lower panel) were determined by Northern blot analysis using 10 mg total RNA. Cells were untreated (7) or treated (+) with camptothecin for 24 h. The relative fold increase in mRNA expression is shown numerically below the upper panel. (c) p53 upregulates EphA2 protein expression. Protein levels of EphA2 (upper panel), p53 (middle panel), and actin (lower panel) were determined by Western blot analysis. Cell extracts were prepared from p53-3 and p53(R249S)-4 cells that were uninduced (7) or induced (+) by tetracycline withdrawal for 24 h and from HCT116 and HCT116-E6 cells that were untreated (7) or treated (+) with camptothecin for 24 h. The upper portion of the blot was probed with anti-EphA2 antibody C-20, the middle portion of the blot was probed with anti-p53 antibodies, and the bottom portion of the blot was probed with anti-actin antibody. The relative fold increase in protein expression is shown numerically below the upper panel creased in cells treated with camptothecin ( Figure 3c ). The increase in tyrosine-phosphorylated EphA2 appears to peak and stabilize between 6 and 8 h after DNA damage (Figure 3c , bottom)
Identification of a p53 response element within the EphA2 promoter
To further con®rm that EphA2 is a true target of the p53 family, we determined whether a p53 response element exists within the EphA2 promoter. To do this, we screened a human bacterial arti®cial chromosome (BAC) library with an EphA2 cDNA probe. A BAC clone containing the EphA2 gene was identi®ed, and approximately 4.0 kb of genomic DNA in the promoter region of the EphA2 gene was sequenced. We found one potential p53 response element (CACCATGTTG gcc AGGCATGTCT), which is located 1678 nucleotides (nt) upstream of the EphA2 open reading frame ( Figure 4a ).
To test whether p53 family members can transactivate gene expression via this putative p53 response element, we performed luciferase reporter assays. The 23-bp response element was cloned upstream of the c- Figure 2 p73 and p63 can induce EphA2. (a) Northern blots were prepared using 10 mg of total RNA isolated from M7-p73b-38, an MCF-7 cell line capable of inducibly expressing p73b. p73b was induced (+) by tetracycline withdrawal for 24 h and endogenous p53 was induced (+) by camptothecin treatment for 24 h. The blots were probed with cDNAs corresponding to the genes as indicated to the right of each blot, and mRNA levels were normalized to GAPDH (lower panel). The fold increase in EphA2 mRNA expression is shown numerically below the upper panel. (b) Western blots were prepared using M7-p73b-38 cell extracts. p73b and p53 were induced as in (a). The blots were probed with anti-EphA2 monoclonal antibody D7, anti-hemagglutinin (HA) antibody 12CA5 to detect HA-tagged p73b, anti-p53 monoclonal antibody Pab240, anti-p21 antibody C19, and anti-actin antibody. The fold increase in EphA2 protein expression is shown numerically below the EphA2 panel. (c) Protein levels of EphA2 (upper panel), p63a (middle panel), and actin (lower panel) in the p63a-inducible cell line p63a-14 were assayed by Western blot analysis. Cell extracts were prepared from uninduced cells (7) and cells induced to express p63a (+) for 24 h. The upper portion of the blot was probed with anti-EphA2 monoclonal antibody D7, the middle portion of the blot was probed with anti-myc antibody 9E10.2 to detect myctagged p63a, and the bottom portion of the blot was probed with anti-actin antibody. The fold increase in EphA2 protein expression is shown numerically below the upper panel fos minimal promoter and a ®re¯y luciferase reporter gene (Johansen and Prywes, 1994) , and the reporter vector was designated p53RE. p53RE was cotransfected into H1299 cells with either a pcDNA3 control vector, a wild-type p53 vector, or a mutant p53 vector. We found that the luciferase activity of the p53RE reporter construct was signi®cantly increased when cotransfected with wild-type p53, but not mutant p53 or a control vector (Figure 4b) . Similarly, transfection of p53RE with wild-type p73a and p73b resulted in an increase in luciferase activity relative to mutant p73a and p73b or a control vector (Figure 4c ). p53RE luciferase activity was also increased when cotransfected with p63a, p63g, and DNp63g (Figure 4d ). Mutation of critical residues within the potential p53 response element (CACAATTTTG gcc AGGAATTT-CT; mutated residues in bold and italics) abrogated the ability of p53 family members to transactivate the mutp53RE reporter construct (Figure 4b ± d).
To determine whether p53 family members can transactivate the potential p53 response element within its natural promoter, we cloned *2.0 kb of the EphA2 promoter, including the potential p53 response element, into a promoter-less luciferase reporter vector. The resulting construct was designated EphA2-luc. As shown in Figure 4e , p53, p73b, p63a and p63g were able to increase the luciferase activity of EphA2-luc. However, the luciferase activity for EphA2-luc was not signi®cantly increased by p53(R175H), p73a, p73a-292, p73b-292, DNp63a and DNp63g (Figure 4e ). Interestingly, simultaneous expression of p53 and p73b resulted in a less-than-additive transactivation of the EphA2-luc reporter (data not shown).
EphA2 induces apoptosis
Many p53 target genes are regulators of cell growth (Levine, 1997) . To determine if EphA2 expression can in¯uence cell growth, we generated H1299 and MCF-7 cell lines that inducibly express EphA2 under a tetracycline-repressible promoter. Representative cell lines, H1299/EphA2-23 and MCF-7/EphA2-116, were shown in Figure 5a . In this system, removal of tetracycline from the culture media induced expression of EphA2 (Figure 5a , upper panel, compare lanes 6 with 5, 8 with 7). The level of EphA2 in H1299/ EphA2-23 cells was comparable to that induced by p53 in HCT116 cells (Figure 5a , upper panel, compare lanes 2 and 6), whereas the level of EphA2 in MCF-7/ EphA2-116 cells was greater than that induced by p53 in HCT116 and MCF-7 cells (Figure 5a , upper panel, compare lanes 2, 4, and 8). The levels of camptothecininduced and tetracycline-regulated p53 were also analysed ( Figure 5a, middle panel) , and the levels of actin were determined as a loading control (Figure 5a , lower panel). To determine whether the overexpressed EphA2 is tyrosine-phosphorylated, we performed an immunoprecipitation assay followed by Western blot analysis. We found that the overexpressed EphA2 in the EphA2 inducible cell lines was also hyperphosphorylated (Figure 5b) . EphA2 and p53 protein levels are increased upon DNA damage. Western blots were prepared using extracts from HCT116 cells treated with 300 nM camptothecin for the indicated times. The upper portion of the blot was probed with anti-EphA2 antibody C-20, the middle portion of the blot was probed with anti-p53 antibody Pab1801, and the bottom portion of the blot was probed with anti-actin antibody. (c) EphA2 phosphorylation is induced by DNA damage. Western blots were prepared using anti-phosphotyrosine and anti-EphA2 immunoprecipitates from HCT116 cell lysates treated with 300 nM camptothecin for the indicated times. The blots were probed with anti-EphA2 antibody C-20. Levels of tyrosine-phosphorylated EphA2 (PY-EphA2) were normalized to total EphA2 protein levels, and the fold increase from multiple ECL exposures is shown graphically below The potential p53 binding site is responsive to wild-type p53 in vivo. The 23-base pair response element was cloned upstream of the c-fos minimal promoter and a ®re¯y luciferase reporter gene, and the reporter vector was designated p53RE. Critical C and G residues within the p53 response element were mutated to A and T, respectively, and the resulting oligomer was cloned into a luciferase reporter vector as above and designated mut-p53RE. p53RE or mut-p53RE were cotransfected into H1299 cells with either pcDNA3 empty vector control or a vector expressing p53 or mutant p53(R175H). Measurements were taken from three separate experiments and normalized with constitutive expression of Renilla luciferase. (c and d) The potential p53 binding site is responsive to p73 and p63 in vivo. As in (b), p53RE or mut-p53RE luciferase reporter vectors were cotransfected with pcDNA3 empty vector control or a vector that expresses p73a, mutant p73a-292, p73b, mutant p73b-292, p63a, DNp63a, p63g, or DNp63g. Measurements were taken from three separate experiments and normalized with constitutive expression of Renilla luciferase. (e) p53 family members can activate the EphA2 promoter. Approximately 2.0 kilobases of EphA2 promoter were cloned into a promoter-less luciferase reporter vector, and the resulting construct was designated EphA2-luc. EphA2-luc was cotransfected with pcDNA3 empty vector control or a vector that expresses one of the p53 family members as shown. Measurements were taken from three separate experiments and normalized with constitutive expression of Renilla luciferase EphA2 receptor tyrosine kinase induces apoptosis M Dohn et al Next, we determined whether EphA2, as a p53 target gene, can inhibit cell growth. We performed growth rate analysis and found that cell proliferation was suppressed when EphA2 was expressed (Figure 5c,d) . Induction of EphA2 severely diminished growth of H1299 cells (Figure 5c ), and EphA2 expression in MCF-7 cells completely abolished cell growth (Figure 5d ). In H1299 cells, inducible expression of p53 reduced cell proliferation to a greater extent than inducible EphA2 expression (data not shown). This is most likely due to the large number of p53 target genes responsible for inducing apoptosis, such as BAX (Miyashita and Reed, 1995) and MCG10 (Zhu and Chen, 2000) . In MCF-7 cells, however, inducible expression of EphA2 reduced cell proliferation to a degree similar to that of inducible p53 expression (data not shown). This result is probably due to the high level of inducible EphA2 expression in this cell line.
The growth rates of parental cells under induced and uninduced conditions were nearly identical (data not shown).
To determine whether the anti-proliferative eect of EphA2 was due to cell cycle arrest, apoptosis, or both, we used DNA histogram analysis to examine the DNA content of EphA2-expressing cells. No signi®cant dierences in cell cycle phase distributions of DNA content were observed in H1299 or MCF-7 cells induced to express EphA2 compared to uninduced cells (Figure 6a ,b and data not shown). This indicates that in H1299 and MCF-7 cells, expression of EphA2 does not contribute to cell cycle arrest. However, EphA2 expression in MCF-7 cells resulted in an increase in the number of cells with a sub-G1 DNA content, which suggests that EphA2 can induce apoptosis. Representative DNA histograms of MCF-7/EphA2-116 cells that were uninduced (7) or induced to express EphA2 (+) for 2 days are shown in Figure   Figure 5 EphA2 negatively regulates cell proliferation. (a) Levels of EphA2 (upper panel), p53 (middle panel), and actin (lower panel) proteins were assayed by Western blot analysis. Cell extracts were prepared from HCT116 cells that were untreated (7) or treated with camptothecin (+) for 24 h (lanes 1 and 2, respectively), MCF-7/p53-24 cells that were uninduced (7) or induced to express p53 (+) for 24 h (lanes 3 and 4, respectively), and H1299/EphA2-23 cells (lanes 5 and 6) and MCF-7/EphA2-116 cells (lanes 7 and 8) that were uninduced (7) or induced to express EphA2 (+) for 24 h. The upper portion of the blot was probed with antiEphA2 antibody, the middle portion of the blot was probed with anti-p53 antibodies, and the bottom portion of the blot was probed with anti-actin antibody. (b) Upregulated EphA2 is hyperphosphorylated. Western blots were prepared using antiphosphotyrosine immunoprecipitates from MCF-7/EphA2-116 and H1299/EphA2-23 cells that were uninduced (7) Figure  6c . Next, we performed a Trypan blue dye exclusion assay. As shown in Figure 6d , cultures induced to express EphA2 contained a higher percentage of Trypan blue positive cells after 3 days of induction compared to uninduced cultures. Furthermore, an annexin V binding assay revealed an increase in the total percentage of annexin V positive cells in EphA2-expressing H1299 cells compared to control H1299 cells (data not shown), and the death eector caspase-3 was activated in H1299 cells in response to EphA2 expression (data not shown). These results suggest that EphA2 can induce apoptosis in H1299 and MCF-7 cells.
Ephrin-A1, a ligand for EphA2, is upregulated by p53 and p73
It has previously been reported that ephrin-A1 and EphB4, two other members of the Eph family of receptor tyrosine kinases and ligands, are upregulated by exogenous p53 and by DNA damaging agents in human colorectal carcinoma cell lines (Yu et al., 1999) . Interestingly, ephrin-A1 is a ligand for the EphA2 receptor (Bartley et al., 1994) . To determine if ephrin-A1 is upregulated by p53 in H1299 cells, we performed Northern blot analysis with RNA from a p53-inducible H1299 cell line. Induction of p53 in this cell line resulted in a substantial increase in ephrin-A1 expression (Figure 7 , upper panel, compare lane 2 with 1). . Levels of p21 WAF1 transcript were assayed as a positive control for p53 and p73b activation, and GAPDH levels were assayed as a loading control (Figure 7, lower panel) . Despite the observed upregulation of ephrin-A1 by p53 and p73b in H1299 and MCF-7 cells, respectively, we were unable to detect an induction of ephrin-A1 in HCT116 cells following treatment with the DNA damaging agent camptothecin (data not shown). Taken together with the ®nding that ephrin-A1 induction by the DNA damaging agent adriamycin appears to be p53-independent (Yu et al., 1999) , the lack of induction by camptothecin indicates that the p53/ephrin-A1 signaling pathway is altered in HCT116 cells.
D.
Subsequent Northern blot analyses with other Eph family members revealed an upregulation of ephrin-B1 by wild-type, but not mutant, p53 (data not shown). We also found that EphA3 and EphB2 were not induced by p53 in H1299 (data not shown), and ephrin-A4 and ephrin-A5 were undetectable in this cell line (data not shown). Furthermore, we found that EphB4 is not induced by p53 in H1299 cells (data not shown). Although EphB4 is upregulated by p53 in DLD-1 colorectal carcinoma cells (Yu et al., 1999) , the lack of EphB4 induction in H1299 lung carcinoma cells is probably due to dierences between the two cell types. In addition, potential p53 response elements are present within the promoter regions of both ephrin-B1 and EphB4 (data not shown).
Discussion
Here we have demonstrated that EphA2 is a target gene of p53 family members, that is, p53, p73, and p63. We have shown that both transcript and protein levels of EphA2 are increased when wild-type p53 or isoforms of p73 and p63 are expressed, and EphA2 activation correlates with p53 stabilization in response to DNA damage. A p53 binding site located within the EphA2 promoter was found to be responsive to wild-type p53, p73, and p63, but not mutant p53 or p73. We have also found that EphA2 suppresses cell proliferation and induces apoptosis when overexpressed. Furthermore, during the preparation of this manuscript, Zhao et al. (2000) reported, using oligonucleotide microarray analysis, that the EphA2 receptor tyrosine kinase is upregulated by p53 and DNA damage.
We have shown that p53 family members are capable of transactivating a luciferase reporter under the control of the putative p53 response element from the EphA2 promoter. We have also shown that the luciferase reporter under the control of the putative p53 response element was more strongly transactivated than that under the control of the EphA2 promoter (see Figure 4) . This is most likely due to in vivo eects of chromatin remodeling. It is well established that the activation of transfected promoter constructs does not always properly re¯ect the activation of endogenous genes (Smith and Hager, 1997) because chromatin remodeling may exert an eect in vivo. Chromatin structure and DNA-binding proteins may contribute to a higher order genomic structure within the EphA2 promoter, which is absent in the smaller constructs containing only the p53 response element. Therefore, it is likely that luciferase assays utilizing the entire EphA2 promoter construct more closely resemble the activation of the endogenous EphA2 gene. Interestingly, simultaneous expression of p53 and p73b resulted in a less-than-additive induction of the luciferase activity for the EphA2-luc reporter vector. This suggests that additional p53 response elements may be present within the endogenous promoter that are not present within the *2.0 kb of promoter used for the experiment. Furthermore, the luciferase experiments were conducted in H1299 because they lack expression of endogenous p53 family members. The additive eect of EphA2 induction by p53 and p73b, however, was observed in MCF-7 cells (see Figure 2a,b) . Therefore, the additive eect of EphA2 induction may be cell type speci®c.
EphA2 has previously been shown to associate with focal adhesion kinase (FAK) (Miao et al., 2000) , a non-receptor tyrosine kinase implicated in the regulation of anchorage-dependent cell survival (reviewed in Rodriguez-Fernandez, 1999) . Activation of EphA2, however, results in the dephosphorylation and inactivation of FAK, most likely by the recruitment of SHP2 protein tyrosine phosphatase (Miao et al., 2000) . Inhibition of FAK signaling causes cells to undergo apoptosis (Hungerford et al., 1996) , whereas constitutive activation of FAK protects MDCK cells from apoptosis caused by loss of contact with the extracellular matrix (Frisch et al., 1996) . Furthermore, the transduction of extracellular matrix survival signals through FAK can suppress p53-mediated apoptosis (Ilic et al., 1998) and induce inhibitor-of-apoptosis proteins (Sonoda et al., 2000) . We have shown here that an upregulation of EphA2 results in an increase in Figure 7 Ephrin-A1 is upregulated by p53 and p73. Transcript levels of ephrin-A1 (upper panel), p21 WAF1 (lower panel), and GAPDH (lower panel) in the p53-inducible cell line p53-3 and the p73b-inducible cell line M7-p73b-38 were determined by Northern blot analysis using 10 mg total RNA. Total RNA was puri®ed from p53-3 and M7-p73b-38 cells that were uninduced (7) or induced (+) by tetracycline withdrawal for 24 h apoptosis, probably through the disruption of FAK signaling. Although it is not yet known whether other members of the Eph family can interact with FAK or induce apoptosis, the upregulation of ephrin-A1 (Yu et al., 1999 , this study), EphB4 (Yu et al., 1999) , and ephrin-B2 (this study) by p53 suggests that Eph family members share a conserved pathway that sensitizes cells to apoptosis. Interestingly, a recent publication by Miao et al. (2001) showed that EphA receptors inhibit the Ras/MAPK pathway. However, the EphA2-dependent inhibition of the Ras/MAPK pathway did not result in an increase in apoptosis (Miao et al., 2001) , which suggests that Ras/MAPK inhibition is not responsible for the increase in apoptosis seen in our EphA2-inducible cell lines.
EphA2 has been shown to be regulated by the cell adhesion receptor E-cadherin (Zantek et al., 1999) . At regions of cell-cell contact, known as adherens junctions, E-cadherin contributes to stable cell adhesions by forming homotypic complexes with other E-cadherin molecules from adjacent cells (Gumbiner, 1996) . However, disruption of E-cadherin function in a tumor cell can lead to aggressive cell migration characteristic of metastasis (for review, see Guilford, 1999) . Interestingly, Zantek et al. (1999) found that inhibition of Ecadherin-mediated adhesion results in the altered distribution and inactivation of EphA2. Additionally, EphA2 has been shown to inhibit cell spreading and migration (Miao et al., 2000) , which suggests that EphA2 and E-cadherin are components of a common signaling pathway. Although it was shown that EphA2 and E-cadherin colocalize to regions of cell-cell contact (Zantek et al., 1999) , it remains to be determined if EphA2 physically interacts with E-cadherin or other proteins found in adherens junctions. Furthermore, it is not yet known whether activity of other Eph family members is regulated by E-cadherin.
We have shown here that the EphA2 receptor tyrosine kinase is upregulated and activated by members of the p53 family, and we have located a p53 binding site within the EphA2 promoter that is responsive to p53 family proteins. We have also demonstrated that the decreased proliferation of EphA2-expressing H1299 and MCF-7 cells is due to an increase in apoptosis. Although the exact mechanism of EphA2-induced apoptosis is not yet clear, we speculate that the EphA2-mediated inactivation of FAK may contribute to an increased sensitization of cells to apoptosis. Further, the apparent role of Eph proteins in cell migration suggests that the inactivation of EphA2 in cancer may play a role in the progression of relatively benign tumors to invasive, metastatic carcinomas.
Materials and methods
Plasmids
EphA2 cDNA was excised from pNeoMSV-EphA2 (kindly provided by T Hunter) and cloned into a tetracyclinerepressible expression vector, pUHD10-3, at its BamHI site. The resulting plasmid was used to generate cell lines that inducibly express EphA2.
Cell culture and cell lines
H1299 is a p53-null non-small cell lung carcinoma cell line. MCF-7 is a breast adenocarcinoma cell line that contains endogenous wild-type p53. Cells were cultured in Dulbecco's Modi®ed Eagle's Medium with 10% fetal bovine serum. H1299 and MCF-7 cell lines that inducibly express EphA2 were generated as described previously (Chen et al., 1996) . Individual clones were screened for inducible expression of EphA2 protein by Western blot analysis using anti-EphA2 antibodies (see below). The H1299 cell lines that inducibly express wild-type p53, mutant p53, and p63a are p53-3, p53(R249S)-4, and p63a-14, respectively, as described previously (Chen et al., 1996; Dohn et al., 2001; Zhu et al., 1999) . p53-7 is a Saos-2 cell line that inducibly expresses wildtype p53 (Chen et al., 1996) . M7-p73b-38 is an MCF-7 cell line that inducibly expresses HA-tagged wild-type p73b.
RNA isolation and Northern blot analysis
Total RNA was isolated from cells using Trizol reagent (Life Technologies, Inc., Gaithersburg, MD, USA). Northern blot analysis was performed as described (Zhu et al., 1998b) . The p21 WAF1 and GAPDH probes were prepared as described previously (Zhu et al., 1998b) . The EphA2 probe was prepared from a 443-bp fragment produced from the digestion of pNeoMSV-EphA2 with BglII and NarI. The following cDNA probes were purchased from Genome Systems, Inc. (St. Louis, MO, USA): EphA3 (GenBank #H38363), EphB2 (T78739), EphB4 (N76569), ephrin-A1 (AA195535), ephrin-A4 (AI289508), ephrin-A5 (R99405), and ephrin-B1 (T65181). Relative fold increase in mRNA expression was determined by densitometric analysis (AlphaImager 2000, Alpha Innotech Corporation, San Leandro, CA, USA).
Western blot analysis
Cells were washed and collected from plates in phosphatebuered saline (PBS), resuspended with 26sample buer, and boiled for 5 min. Western blot analysis was performed as described previously (Chen et al., 1996) . Anity puri®ed antiactin polyclonal antibody was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Anti-p21 polyclonal antibody C19 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-myc monoclonal antibody 9E10.2 was purchased from American Type Culture Collection (Rockville, MD). Anti-EphA2 polyclonal antibody C-20 and monoclonal antibody D7 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and Upstate Biotechnology (Lake Placid, NY, USA), respectively. Monoclonal antibodies used to detect p53 were Pab240, Pab421, and Pab1801. p73b was detected with anti-HA 12CA5 monoclonal antibody (Sigma Chemical Co., St. Louis, MO, USA). Relative fold increase in protein expression was determined by densitometric analysis (AlphaImager 2000, Alpha Innotech Corporation, San Leandro, CA, USA).
Immunoprecipitation
Subcon¯uent HCT116 and MCF-7 cells were untreated or treated with camptothecin (300 nM). Subcon¯uent H1299/ EphA2-23 and MCF-7/EphA2-116 cells were uninduced or EphA2 receptor tyrosine kinase induces apoptosis M Dohn et al induced to express EphA2 for 24 h. At indicated times, cells were placed on ice, washed twice with cold 16PBS, and lysed for 15 min in modi®ed RIPA lysis buer (150 mM NaCl; 50 mM Tris-Cl, pH 8.0, 2 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 1 mM PMSF; 2 mM leupeptin; 1 : 100 aprotinin; 1 mM NaVO 4 ). After three freeze/thaw cycles and clari®cation by centrifugation, about 200 mg protein in 250 ml of lysate were pre-cleared with 50 ml IgG-Sorb (Enzyme Center, Malden, MA, USA) for 1.5 h at 48C. Tyrosine phosphorylated proteins were immunoprecipitated at 48C overnight with 50 ml of agarose-conjugated antiphosphotyrosine antibodies (4G10; Upstate Biotechnology, Lake Placid, NY, USA). EphA2 was immunoprecipitated with 1.0 ml anti-EphA2 antibody (B2D6; Upstate Biotechnology, Lake Placid, NY, USA) and 50 ml 50% protein-A beads (Sigma Chemical Co., St. Louis, MO, USA) to capture the antibody-antigen complex. Pellets were washed three times with modi®ed RIPA lysis buer, resuspended in 50 ml 26SDS ± PAGE sample buer, boiled for 10 min, and resolved on an 8% SDS ± PAGE gel.
EphA2 promoter sequencing
Human bacteria arti®cial chromosome (BAC) ®lters (Genome Systems, St. Louis, MO, USA) were probed with EphA2 cDNA according to the manufacturer's instructions. A positive clone was subcloned into the pZERO cloning vector (Invitrogen, Carlsbad, CA, USA) at the EcoRI cloning site. Subsequent subclones were screened with EphA2 cDNA, and a clone containing *4.0 kilobases (kb) of DNA directly upstream of the EphA2 translational start codon was identi®ed and sequenced.
Luciferase assay
The 23-bp putative p53 response element (5'-CAC CATG TTG gcc AGG CATG TCT-3'; critical residues in bold; lower case indicates spacer residues between two half-sites (elDeiry et al., 1992)) was cloned upstream of a minimal c-fos promoter and a ®re¯y luciferase gene (Johansen and Prywes, 1994) , and the resulting vector was designated p53RE. Critical C and G residues were mutated to A and T, respectively, and the resulting oligomer (5'-CAC AATT TTG gcc AGG AATT TCT-3'; mutated residues in bold and italics) was cloned as above and designated mutp53RE. 2016 bp of EphA2 promoter, including the putative p53 response element, was cloned into a promoter-less ®re¯y luciferase expression vector (pGL2-Basic; Promega, Madison, WI, USA) and designated EphA2-luc. 2.0 mg of pcDNA3 or a vector expressing p53, mutant p53(R175H), p73a, mutant p73a-292, p73b, mutant p73b-292, p63a, DNp63a, p63g or DNp63g were cotransfected into H1299 cells with 1.0 mg of either p53RE, mut-p53RE, or EphA2-luc. For an internal control, 25 ng of the Renilla luciferase vector pRL-CMV (Promega, Madison, WI, USA) were cotransfected with the above constructs. Transfections were performed as described (Chen and Okayama, 1987) , and dual luciferase assays were performed in triplicate according to the manufacturer's instructions (Promega, Madison, WI, USA).
Growth rate analysis
Cells were seeded at approximately 1.4610 5 /60-mm plate with or without tetracycline (1.0 mg/ml). The medium was replaced every 72 h. At the times indicated, two plates were rinsed with PBS twice to remove dead cells and debris. Live cells were trypsinized, and cells from each plate were collected separately and counted four times using a Coulter cell counter (Coulter Corporation, Miami, FL, USA). The average number of cells from each plate was used for growth rate determination.
DNA histogram analysis
Cells were seeded at 2.0610 5 /90-mm plate, with or without tetracycline (1.0 mg/ml). Three days after plating, both oating dead cells in the medium and live cells on the plate were collected and ®xed with 1 ml of 75% ethanol for at least 1 h at 48C. The ®xed cells were centrifuged and resuspended in 0.5 ml PBS containing 20 mg/ml of RNase A (Sigma Chemical Co., St. Louis, MO, USA) and 50 mg/ml of propidium iodide (Sigma Chemical Co., St. Louis, MO, USA). The stained cells were analysed in a¯uorescence-activated cell sorter (FACSCaliber; Becton Dickinson, Menlo Park, CA, USA) within 4 h.
Trypan blue dye exclusion
Trypan blue dye staining is based on the principle that certain dyes will not stain live, viable cells, whereas dead, nonviable cells are permeable and susceptible to staining. Cells were seeded at approximately 7.0610 4 /60-mm plate with or without tetracycline (1.0 mg/ml). Three days after plating, live and dead cells from two plates were collected separately and mixed with an equal volume of 0.4% Trypan blue dye solution (Sigma Chemical Co., St. Louis, MO, USA) for 15 min. Stained (dead) and unstained (live) cells were counted using a hemocytometer, and the percentage of dead cells/total cells was determined by scoring an average of more than 300 cells, twice per plate. Abbreviations HA, hemagglutinin; PBS, phosphate buered saline; kb, kilobase; bp, base pair; FACS,¯uorescence-activated cell sorting; HPV, human papilloma virus; nt, nucleotide; FAK, focal adhesion kinase.
